IDEXX Laboratories

YTD

ALL

Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IDXX

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other.

CEO

Michael Erickson

CEOMichael Erickson

Employees

11,000

Employees11,000

Headquarters

Westbrook, Maine

HeadquartersWestbrook, Maine

Founded

1983

Founded1983

Employees

11,000

Employees11,000

IDXX Key Statistics

Market cap

43.60B

Market cap43.60B

Price-Earnings ratio

40.73

Price-Earnings ratio40.73

Dividend yield

—

Dividend yield—

Average volume

637.28K

Average volume637.28K

High today

$556.72

High today$556.72

Low today

$539.44

Low today$539.44

Open price

$548.06

Open price$548.06

Volume

426.74K

Volume426.74K

52 Week high

$769.98

52 Week high$769.98

52 Week low

$496.61

52 Week low$496.61

Stock Snapshot

As of today, IDEXX Laboratories(IDXX) shares are valued at $551.69. The company's market cap stands at 43.6B, with a P/E ratio of 40.73.

During the trading session on 2026-05-22, IDEXX Laboratories(IDXX) shares reached a daily high of $556.72 and a low of $539.44. At a current price of $551.69, the stock is +2.3% higher than the low and still -0.9% under the high.

Trading activity shows a volume of 426.74K, compared to an average daily volume of 637.28K.

The stock's 52-week range extends from a low of $496.61 to a high of $769.98.

IDXX News

MarketWatch 1d

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Simply Wall St 2d

IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate

IDEXX Laboratories (NasdaqGS:IDXX) has integrated the SDMA kidney biomarker into its most widely used Catalyst in-clinic chemistry profiles. The update allows...

TipRanks 3d

Idexx Laboratories announces SDMA to be built into Catalyst CLIPs

IDEXX Laboratories (IDXX) announced that SDMA, a renal biomarker, will be built into Catalyst CLIPs, making complete kidney function evaluation part of the most...

Analyst ratings

47%

of 15 ratings

Buy

46.7%

Hold

46.7%

Sell

6.7%

More IDXX News

Simply Wall St 6d

Idexx Laboratories Valuation Check After Strong Q1 2026 Results And Raised Outlook

IDEXX Laboratories (IDXX) is back in focus after first quarter 2026 results and a higher full year outlook, with revenue, earnings and management guidance now g...

TipRanks 6d

Idexx Laboratories Shareholders Approve Governance and Meeting Reforms

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

People also own

Based on the portfolios of people who own IDXX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.